MXRA5 and benign prostatic hyperplasia: In contrast to MXRA5 silenced stromal cells, the percentage of MXRA5 transfected BPH-1 cells at the G0/G1 phase was decreased while the percentage of cells at the G2 phase was increased (Figure 9A, Figure 9B).